Ken Griffin Icon PLC Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$280.48 - $346.2 $5.89 Million - $7.27 Million	-21,000 Reduced 62.87%	12,400 $3.56 Million
Q2 2024 Aug 14, 2024	BUY	$288.23 - $331.73 $6.31 Million - $7.26 Million	21,900 Added 190.43%	33,400 $10.5 Million
Q1 2024 May 15, 2024	BUY	$247.84 - $340.0 $693,952 - $952,000	2,800 Added 32.18%	11,500 $3.86 Million
Q4 2023 Feb 14, 2024	SELL	$222.83 - $285.76 $6.13 Million - $7.86 Million	-27,500 Reduced 75.97%	8,700 $2.46 Million
Q3 2023 Nov 14, 2023	BUY	$236.44 - $265.62 $1.51 Million - $1.7 Million	6,400 Added 21.48%	36,200 $8.91 Million
Q2 2023 Aug 14, 2023	SELL	$183.12 - $250.2 $2.36 Million - $3.23 Million	-12,900 Reduced 30.21%	29,800 $7.46 Million
Q1 2023 May 15, 2023	BUY	$193.59 - $245.33 $6.16 Million - $7.8 Million	31,800 Added 291.74%	42,700 $9.12 Million
Q4 2022 Feb 14, 2023	SELL	$173.9 - $224.8 $1.03 Million - $1.33 Million	-5,900 Reduced 35.12%	10,900 $2.12 Million
Q3 2022 Nov 14, 2022	SELL	$183.25 - $247.5 $714,675 - $965,250	-3,900 Reduced 18.84%	16,800 $3.09 Million

703

75.7M

169K

58.4K

Ticker ICLR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 81,526,600
Market Cap $15.5B
Description
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.